Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Case report: cholangiocarcinoma and hypercalcemia

J M Davis1, R Sadasivan, T Dwyer

  • 1Division of Clinical Oncology, University of Kansas Medical Center, Kansas City 66160-7353.

The American Journal of the Medical Sciences
|May 1, 1994
PubMed
Summary

Hypercalcemia, a common cancer complication, can be life-threatening. This study details parathyroid hormone-related protein production in adenocarcinoma-cholangiocarcinoma, offering insights into cancer-related hypercalcemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of ethanol administration and withdrawal on serotonin receptor subtypes and receptor-mediated phosphoinositide hydrolysis in rat brain.

Alcoholism, clinical and experimental research·1992
Same author

Effects of brief, heavy exertion on circulating lymphocyte subpopulations and proliferative response.

Medicine and science in sports and exercise·1992
Same author

Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients.

Schizophrenia research·1992
Same author

Monoamine oxidase and cortisol response in depression and schizophrenia.

Psychiatry research·1992
Same author

Platelet monoamine oxidase in schizophrenia: a meta-analysis.

Schizophrenia research·1992
Same author

Effect of electroconvulsive shock on 5-HT2 and alpha 1-adrenoceptors and phosphoinositide signalling system in rat brain.

European journal of pharmacology·1992

Area of Science:

  • Oncology
  • Endocrinology
  • Pathology

Background:

  • Hypercalcemia is a frequent and serious metabolic complication in cancer patients.
  • Malignancy is the leading cause of hypercalcemia in hospitalized individuals, affecting 10-20% of cancer patients.
  • It often signifies advanced disease, with bone metastasis being the most common cause.

Observation:

  • A subset of patients (15%) develop hypercalcemia through non-metastatic mechanisms, termed humoral hypercalcemia of malignancy.
  • This condition is linked to cytokine secretion, notably parathyroid hormone-related protein (PTHrP).
  • This case report focuses on an adenocarcinoma-cholangiocarcinoma.

Findings:

  • The study documents PTHrP production by an adenocarcinoma-cholangiocarcinoma.

Related Experiment Videos

  • PTHrP was confirmed through serum measurements and immunohistochemical staining of tumor tissue.
  • This provides direct evidence of PTHrP secretion by this specific tumor type.

    • Implications:

    • This finding expands the understanding of humoral hypercalcemia of malignancy.
    • It highlights the importance of considering PTHrP in non-metastatic hypercalcemia of cancer.
    • Further research into PTHrP's role may lead to targeted therapies for cancer-associated hypercalcemia.